Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

New analysis highlights effectiveness of low-dose CT lung cancer screening

While the incidence of lung cancer did not significantly differ from start to finish, stage-specific incidence did.

Radiologists' understanding of tumor 'mimics' vital when assessing bone and soft tissue lesions

Authors of the new EJR paper explained that, although most of these tumors present in a similar way—with a lump or localized pain—their origins are wide-ranging and require the use of additional imaging to characterize the lesion.

Surveillance breast MRI findings linked with future second cancer

The new research focused specifically on associations between background parenchymal enhancement—a known risk factor for breast cancer, visualized on surveillance MRI exams—and secondary breast cancers.

Two examples of PSMA-PET scans showing numerous prostate cancer metastases spread throughout the body. Many of these smaller tumors would not have been dected on previous standard-of-care imaging. Photo on left courtesy of SNMMI, right University of Chicago. #PSMAPET

PSMA-PET is rapidly changing the standard of care for prostate cancer patients

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

MR-directed enhanced mammography detects more malignancies than MR-directed ultrasound

MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected.

Fully automated CT body composition analysis predicts survival for CRC patients

A fully automated body composition analysis derived from CT imaging can be a valuable pretreatment tool for patients with colorectal cancer.

non-small cell lung cancer tumor segmentation

Algorithm reduces NSCLC tumor segmentation times by 65%

In a close collaboration with radiation oncologists, experts trained their model on the CT lung images of 787 patients and tested it on the scans of more than 1,300 patients from external datasets.

Cancer patients who undergo PCI face a higher risk of early mortality

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care